CarDiaLogue

#CarDiaLogue

Join the CarDiaLogue

This platform is the one stop content site for healthcare professionals passionate about cardiovascular disease management.

 

Sign up

Latest perspectives

 

CarDiaLogue unites the passion for cardiology and diagnostics in an engaging dialogue.

Prof. Carolyn Lam: the important milestones achieved in the ADOPT study
 

It was our pleasure to meet Prof. Carolyn Lam from the National Heart Centre, Singapore, and discuss this significant study to learn how it is moving forward.

ADOPT is a prospective, multinational randomized open-label study conducted in APAC (Taiwan, China, India, Malaysia, and Singapore) aiming to include 2,400 adults with type 2 DM without known cardiovascular disease.

This trial is investigating whether intensive preventive therapy (high dose renin-angiotensin-aldosterone system inhibitors, beta-blockade, sodium-glucose co-transporter 2 inhibitors) among biomarker (NTproBNP) identified high-risk type 2 DM patients without pre-existing cardiovascular disease, may be associated with reduced cardiovascular events compared to standard of care.

CarDiaLog Campaign Image - Table and Heart

Interview with Mathias Egermark

I hope we will look back at 2020 as a year when COVID-19 taught us valuable lessons on how we can recognize the value of in vitro diagnostics and biomarkers.

 

Life Cycle Leader Cardiac & Critical Care, Women's Health and Personalized Healthcare, Roche Diagnostics

Impact of the corona crisis

 

Mathias Egermark shares his thoughts on the burden of cardiovascular diseases, the impact of the corona crisis on the perception of diagnostics, and the willingness to adopt innovation. He also shares some personal events by which he will remember 2020.

Opportunities to improve treatment efficiency

 

Mathias Egermark discusses the opportunities to improve treatment efficiency and outcomes in cardiovascular disease management, using a combination of wet biomarkers and digital technology. He also shares his vision of the improvement of cardiac care in the future.

CarDiaLog Campaign Image - Table and Heart

How will the new European Diagnostics regulations affect our Clinical practice, research and innovation?

 

Listen to the interesting discussion between Prof. Christa Cobbaert (Leiden University Medical Centre), Prof. Christian Mueller (University Hospital of Basel) and Prof. Christian Zaugg (Roche Diagnostics).

CarDiaLogue unites the passion for cardiology and diagnostics in an engaging dialogue

Join the #CarDiaLogue today and sign up for updates.

CarDiaLogue brings you the latest insights and valuable perspectives from some of the sharpest minds in cardiology to complement your specialist skills.

Form Successfully Submitted!
Thank you for your submission!
text

Related information

Berlin

Virtual proCardio

 

proCardio is a unique scientific event in the field of biomarkers in cardiovascular medicine proCardio has been recognized as a highly successful and engaging scientific event featuring a world-class international faculty to discuss cardiac biomarkers. We communicate the latest evidence and clinical trial data related to the use of cardiac biomarkers.

See more

Illustration - Healthcare Transformers

Healthcare Transformers

 

Content hub dedicated for c-suite professionals/executive leaders and other decision makers in healthcare, specifically diagnostics. Platform which inspires our readers to solve healthcare transformation challenges in a new way.

Roche Healthcare Transformers

Illustration - Healthcare Transformers

CardioThinkLab platform

 

Scientific educational portal for healthcare professionals passionate about cardiovascular disease management. Aiming to provide new horizons of diagnostics and digital advancements to partner physicians in improving patient outcomes in the Asia and the Pacific region.

CardioThinkLab platform